↓ Skip to main content

Phase II study of intraperitoneal recombinant interleukin-12 (rhIL-12) in patients with peritoneal carcinomatosis (residual disease < 1 cm) associated with ovarian cancer or primary peritoneal…

Overview of attention for article published in Journal of Translational Medicine, December 2007
Altmetric Badge

Citations

dimensions_citation
68 Dimensions

Readers on

mendeley
51 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Phase II study of intraperitoneal recombinant interleukin-12 (rhIL-12) in patients with peritoneal carcinomatosis (residual disease < 1 cm) associated with ovarian cancer or primary peritoneal carcinoma
Published in
Journal of Translational Medicine, December 2007
DOI 10.1186/1479-5876-5-66
Pubmed ID
Authors

Renato Lenzi, Robert Edwards, Carl June, Michael V Seiden, Michael E Garcia, Michael Rosenblum, Ralph S Freedman

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 51 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 2%
Unknown 50 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 12 24%
Student > Bachelor 5 10%
Student > Ph. D. Student 5 10%
Student > Doctoral Student 4 8%
Student > Master 4 8%
Other 8 16%
Unknown 13 25%
Readers by discipline Count As %
Medicine and Dentistry 10 20%
Immunology and Microbiology 7 14%
Biochemistry, Genetics and Molecular Biology 6 12%
Agricultural and Biological Sciences 5 10%
Nursing and Health Professions 2 4%
Other 4 8%
Unknown 17 33%